key: cord-0925510-upkq32m4
authors: Dejani, Naiara Naiana; Elshabrawy, Hatem A.; Bezerra Filho, Carlos da Silva Maia; de Sousa, Damião Pergentino
title: Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives
date: 2021-08-23
journal: Biomolecules
DOI: 10.3390/biom11081254
sha: 3312b66cd458c4ca89ba9171482758746e8cc873
doc_id: 925510
cord_uid: upkq32m4

In 2019, COVID-19 emerged as a severe respiratory disease that is caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The disease has been associated with high mortality rate, especially in patients with comorbidities such as diabetes, cardiovascular and kidney diseases. This could be attributed to dysregulated immune responses and severe systemic inflammation in COVID-19 patients. The use of effective antiviral drugs against SARS-CoV-2 and modulation of the immune responses could be a potential therapeutic strategy for COVID-19. Studies have shown that natural phenolic compounds have several pharmacological properties, including anticoronavirus and immunomodulatory activities. Therefore, this review discusses the dual action of these natural products from the perspective of applicability at COVID-19.

Coronaviruses (CoVs) are positive single-stranded (+ss) RNA viruses belonging to family Coronaviridae [1] . A large number of CoVs have been discovered as the causative agents of diseases in animals and humans [2] . Seven human CoVs (HCoVs) were discovered to date and they have all been linked to respiratory diseases. Four HCoVs cause mild diseases; whereas three HCoVs are the causative agents of severe respiratory diseases [3, 4] . Of those three HCoVs, Severe Acute Respiratory Syndrome-CoV (SARS-CoV) was the first discovered in 2002-2003, followed by Middle East Respiratory Syndrome-CoV (MERS-CoV) in 2012, and finally the causative agent of the current COVID-19 pandemic; SARS-CoV-2 in 2019 [3, 4] . SARS-CoV-2 was first discovered in patients that were linked to Huanan Seafood Market in Wuhan, China [4] . Since its emergence according to World Health Organization (WHO), millions of COVID-19 cases have been reported worldwide with over 4 million deaths. The severity of the diseases associated with SARS-CoV, MERS-CoV, and SARS-CoV-2 and the high fatality rates have prompted several research groups to develop effective antivirals against coronaviruses. Natural products have shown antiviral activities against several viruses including coronaviruses [5] . Of these natural products, phenolic compounds have shown a wide range of pharmacological activities [6] .

Phenolic compounds are chemically characterized by having at least one aromatic rings attached to one or more hydroxyl substituent, and more than 8000 phenolic compounds have already been identified in plants [7] . Several plant families contain phenolic

Since the emergence of SARS-CoV-2 in December 2019, several studies have focused on repurposing drugs that have been used for other health conditions including drugs with reported anti-SARS-CoV activity. In line with that, flavonoids that inhibited SARS-CoV were tested against SARS-CoV-2. In one study, quercetin and EGCG were shown to interact with and inhibit SARS-CoV-2 3CL pro activity in a FRET-based enzymatic assay [34, 35] . Moreover, EGCG inhibited the entry of SARS-CoV-2-pseudotyped virus and live SARS-CoV-2 into HEK293T-hACE2 and Vero cells respectively [36] . Another study has demonstrated that EGCG inhibited the endoribonuclease enzymatic activity of SARS-CoV-2 nonstructural protein-15 (Nsp15) with an IC 50 of 1.62 µM, while blocking viral replication in Vero cells with an IC 50 , 0.2 µM [37] . The low IC 50 of ECGC indicates its potency and warrants its further development as a potential SARS-CoV-2 antiviral. GCG was also found to inhibit the binding of SARS-CoV-2 N protein to viral RNA inhibiting viral replication in A549-hACE2 with an IC 50 , 44.4 µM [38] . As shown previously with SARS-CoV 3CL pro , herbacetin and pectolinarin inhibited SARS-CoV-2 3CL pro with an IC 50 of 53.90 and 51.64 µM, respectively [28, 39] . However, rhoifolin exhibited weaker inhibition, whereas baicalin showed stronger inhibition of SARS-CoV-2 3CL pro than that observed for SARS-CoV 3CL pro . These differences in inhibition of 3CL pro by rhoifolin and baicalin may be attributed to the slight differences in the amino acid sequence since the two 3CL pro have 96% sequence identity. A study has also demonstrated potent inhibition of recombinant SARS-CoV-2 3CL pro by myricetin, which suggests that myricetin could be further tested and developed as a potential SARS-CoV-2 antiviral [40] .

A recent study that screened for inhibitors of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 receptor, identified the flavonoids rutin, quercetin, and tamarixetin as inhibitors of ACE2 activity [41] . However, the most potent of all flavonoids tested was quercetin with an IC 50 of 4.48 µM.

Stilbene derivatives, such as resveratrol, are natural polyphenolic compounds that are abundant in a variety of plants including grapes [42] . They have a wide range of activities including antimicrobial, antioxidant, antileukemic, anti-platelet aggregative, protein tyrosine kinase inhibitory, anti-inflammatory, anticarcinogenic activity, antiviral activities [42] . Several studies evaluated resveratrol and its derivatives for their antiviral activity against SARS-CoV, SARS-CoV-2, and MERS-CoV [42] [43] [44] . Resveratrol and a few derivatives showed potent inhibition of SARS-CoV replication [42] . Resveratrol also inhibited MERS-CoV viral replication, nucleocapsid protein expression, and protected MERS-CoV infected cells from apoptosis [43] . Most recently, a study showed that resveratrol inhibited SARS-CoV-2 infection of Vero cells [44] . This study suggests that resveratrol inhibits the entry of virus into Vero cells. In addition to the above studies, several molecular docking and computational studies have described different flavonoids that target SARS-CoV-2 S protein, 3CL pro , PL pro , helicase and RNA polymerase [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] . Molecular docking studies have also identified resveratrol, quercetin, and luteolin as phenolic compounds that binds with high affinity to ACE2 receptor [63, 64] .

All the previous activities of flavonoids and phenolic compounds indicate that they may serve as promising and potential therapeutics for SARS-CoV-2 and could be considered for further development. Table 1 summarizes the anticoronavirus activities of phenolic compounds discussed in this study. PEDV infection of Vero cells and Sulforhodamine B assay for cytotoxicity [21] Luteolin and Quercetin Cell-free assay using recombinant 3CL pro fusion protein and substrate Cell-based assay using recombinant 3CL pro -substrate-luciferase fusion protein [25] Amentoflavone Inhibition of SARS-CoV 3CL pro 8.3 µM --FRET assay using commercial 3CL pro [26] GCG and EGCG Inhibition of SARS-CoV 3CL pro GCG: 47 µM EGCG: 73 µM --FRET assay using recombinant 3CL pro [27] Herbacetin, Rhoifolin and Pectolinarin [33] Quercetin Inhibition of SARS-CoV-2 3CL pro ---FRET assay using recombinant SARS-CoV-2 3CL pro [34] EGCG Inhibition of SARS-CoV-2 3CL pro 0.874 ± 0.005 µM --FRET assay using recombinant SARS-CoV-2 3CL pro [35] EGCG Inhibition of viral entry by blocking the binding of SARS-CoV-2 S protein to ACE2

3.77 µM --Plaque reduction assay using live SARS-CoV-2 [36] EGCG Inhibition of endoribonuclease activity of SARS-CoV-2 Nsp15

1.62 µM and 0.2 µM in enzymatic assay and live virus infection assay respectively --FRET assay using recombinant NSP15 and live SARS-CoV-2 palque reduction assay [37] GCG Inhibition of binding of SARS-CoV-2 N protein to viral RNA 44.4 µM 155.4 µM 3.5 SARS-CoV-2 infection of A549-hACE2 cells [38] Herbacetin, Pectolinarin

Inhibition of SARS-CoV-2 3CL pro Herbacetin: 53.90 µM Pectolinarin: 51.64 µM --FRET assay using recombinant SARS-CoV-2 3CL pro [39] Myricetin Inhibition of SARS-CoV-2 3CL pro 3.684 ± 0.076 µM --FRET assay using recombinant SARS-CoV-2 3CL pro [40] Quercetin Inhibition of ACE2 4.48 µM --FRET assay using recombinant ACE2 and Mca-APK(Dnp) as the substrate [41] Resveratrol Inhibition of MERS-CoV viral RNA replication, nucelocapsid protein expression, and MERS-CoV-mediated cell apoptosis Inhibiton of SARS-CoV-2 viral entry 4.48 µM >200 µM >45

Live MERS-CoV infection assays such as plaque assay, MTT, and neutral red uptake assay as well as immunofluorescent assay Live SARS-CoV-2 infection of Vero cells [43] [ 44] 

Immune responses to viral infections are essential to control viral replication, kill infected cells and induce protective immunity against virus [65, 66] . Following infection, viral nucleic acid and viral proteins are detected by patter recognition receptors (PRRs), such as Toll-like receptors (TLRs) on immune cells and other cells [65] . The recognition of viral proteins and nucleic acid results in production of inflammatory cytokines, chemokines and adhesion molecules by immune tissue resident cells, such as macrophages [67] . Although appropriate levels of proinflammatory cytokines are required to activate immune cells involved in viral control, extremely high levels of IL-1β, IL-10, G-CSF, GM-CSF, IFN-γ and TNF-α were detected in COVID-19 patients [68] . Moreover, disease severity positively correlated with increased IL-6 levels [69] .

Type I interferon (IFN) is required to activate cellular antiviral mechanisms to suppress viral replication and virion assembly [70] . Severe COVID-19 patients demonstrated decreased type I IFN response and exacerbated inflammation [71] . Indeed, autoantibodies against type I IFN were detected in severe COVID-19 pneumoniae [72] and mutations in genes related to type I IFN immunity were also detected in critical patients [73] . Besides the host defects in type I IFN immunity, a study showed that SARS-CoV-2 ORF6 protein inhibited type I interferon production and signaling pathway [74] . In addition, natural killer (NK) cell numbers were reduced in blood of severe COVID-19 patients [75] . Therefore, impaired innate immune responses and increased production of proinflammatory cytokines may contribute to disease severity and worse outcomes in COVID-19 patients.

In addition to innate immune system deficiencies reported in severe COVID-19 patients, adaptive immune responses are also compromised as demonstrated by lymphopenia and decreased numbers of T cells in severe COVID-19 patients [76] . Direct viral cytotoxicity, impaired cell proliferation and enhanced apoptosis have been related to lymphopenia in severe COVID-19 patients [77] . Increased levels of C-reactive protein (CRP), D-dimer, fibrinogen, procalcitonin, lactate dehydrogenase (LDH), and ferritin have also been reported in severe COVID-19 patients [78, 79] . The immune dysregulation during COVID-19 results in hyperinflammation, pulmonary injury, coagulopathy and multiorgan dysfunction, leading to worse outcome [80] . Indeed, comorbidities, including hypertension, diabetes and obesity, are prevalent in severe COVID-19 patients [81] [82] [83] .

Natural products with immunomodulatory activities are worth investigation as promising therapeutics for COVID- 19 . In addition to antiviral activity, many natural products have antifungal and antibacterial activities, which are interesting since coinfections have been reported in severe SARS-CoV-2 pneumonia patients [84] . Anti-inflammatory, antiapoptotic, antioxidant, and immunomodulatory activities have been described for natural compounds [85] [86] [87] [88] . Indeed, natural compounds capable of reducing inflammation without compromising host immunity would be beneficial for treatment of severe COVID-19 [80] . Herein, we review the immunomodulatory activities of natural phenolic compounds, including flavonoids, that possess anti-SARS-CoV, anti-MERS-CoV, and anti-SARS-CoV-2 activities.

A variety of natural compounds have shown anti-inflammatory and antioxidant activities in addition to immunomodulatory activities that are reported in different experimental models [87] [88] [89] (Table 2 ). Apigenin and luteolin at 10 µM induced activation of NK and CD8 + T cells (CTLs) in vitro, and enhanced the proliferation of splenocytes stimulated with lipopolysaccharide (LPS) [90] .

EGCG enhanced the antiviral state in Huh7 cells, a hepatoma cell line, infected with hepatitis C virus (HCV) [91] . Treatment of HCV-infected Huh7 cells with 10 µM of EGCG enhanced polyinosinic-polycytidylic acid (Poly I:C) induced expression of IFN-stimulated genes (ISGs), increased TLR3 and IFN-λ1 expression, and decreased viral replication [91] . Indeed, pretreatment of Huh7 cells with 10 µM epigallocatechin gallate followed by HCV dsRNAs enhanced antiviral defense that is mediated by interferon-λ1 (IFN-λ1), TLR3, RNA-sensing retinoic acid-inducible gene I (RIG-I) and IFN-stimulated gene (ISG) expression [92] . In a murine leukemia model, oral treatment with 87.26 µmol/kg of EGCG induced T and B cell proliferation and NK cell activity [93] . Furthermore, EGCG (50 µM) increased macrophage receptor with collagenous structure (MARCO) expression and improved macrophage phagocytosis of Streptococcus pneumoniae [94] . Ex vivo experiments using cells from mice orally treated, every day for 6 weeks, with 1000 mg/kg of EGCG fraction of green tea extract demonstrated enhanced innate and adaptive immune responses such as NK cytolysis, peritoneal cells phagocytosis, splenocyte proliferation, and IL-2 and IFN-γ production [95] .

Quercetin, resveratrol and apigenin were also reported to have antimicrobial and immunostimulatory activities [88, 96, 97] . Mice fed with quercetin (0.86 µmol day −1 ) for 34 days and immunized at day 29 with forssman heterophilic glycolipid antigen, a T celldependent antigen, showed increased ex vivo B and T cell proliferation as well as enhanced numbers of IgM-producing lymphocytes [98] . During in vitro viral infection, macrophages treated with a noncytotoxic concentration of quercetin (100 µM) showed impaired dengue virus type 1 and type 3 (DENV1, DENV3) replication and diminished TNF-α and IL-6 secretion by human U937-DC-SIGN macrophages in the presence or absence of enhancing 4G2 antibodies, whereas resveratrol (100 µM) and apigenin (40 µM) only impaired DENV3 replication in the absence of enhancing antibodies [96] . On the other hand, quercetin (10 µM) and resveratrol (50 µM) suppressed human metapneumovirus (hMPV) replication, decreased 8-isoprostane, an oxidative stress marker, and reduced IL-8, RANTES, IL-6, TNF-α, CXCL-10, CCL4 production by hMPV-infected A549 airway epithelial cell line [99] .

Resveratrol at 25 µM inhibited influenza virus replication through activation of TLR9/MyD88/IRF7 pathway in A549 infected cells, and enhancing IFN-β production [97] . Also, pre-treatment of RAW 264.7 cells with 100 µg/mL of aqueous extract of Eupatorium fortune demonstrated antiviral activity against influenza A virus infection by enhancing production of type I IFN. Indeed, quercetin was identified as one of the active antiviral and immunomodulatory compounds of the extract [100] . This was confirmed by a study which showed that pre-treatment with 3.0 µg/mL quercetin inhibited influenza virus replication in RAW 264.7 cells and increased IFN-β production [101] . Moreover, quercetin dose dependently decreased nontypeable Haemophilus influenzae (NTHi) bacterial viability in vitro, reduced production of proinflammatory markers in the lungs of infected mice that were pre-treated with 60 mg/kg for 8 days and for 24h postinfection, and decreased mortality of NTHi-infected zebrafish that were intraperitoneally treated with 0.3 mg/g of quercetin at 29 and 53h postinfection [102] .

Hesperetin is another flavonoid with antioxidant, anti-inflammatory, anticancer and antimicrobial activity [103, 104] . It has been shown that hesperetin (25 µM) activated host cellular and humoral responses [105] , enhanced LPS-mediated in vitro proliferation of splenocytes, and potentiated killing activity of NK and CTLs [105] . Moreover, hesperetin activated antigen presenting cells (APCs), enhanced CTL response, and antitumor immunity when used as an adjuvant at 2.65 µmol/mouse in combination with inactivated B16F10 melanoma cells vaccine which prolonged the survival of tumor-bearing mice [106] . 

 CTL and NK cytotoxicity activity [90] Poly I:C induced expression of ISGs   [91] T and B cell proliferation NK activity Macrophage phagocytosis [93] DENV1 and DENV2 replication TNF-α and IL-6 secretion [96] B cells proliferation IgM-producing lymphocytes [98] Oxidative stress 

Reference  CTL and NK cytotoxicity activity [90] Poly I:C induced expression of ISGs   [91] T and B cell proliferation NK activity Macrophage phagocytosis [93] DENV1 and DENV2 replication TNF-α and IL-6 secretion [96] s B cells proliferation IgM-producing lymphocytes [98] Oxidative stress decreased.

It has been established that activated nuclear factor-κB (NF-κB) translocates to the nucleus and induces the transcription of genes involved in inflammation, apoptosis, cell proliferation, survival, and differentiation [107] . Since NF-κB drives the expression of cytokines and others inflammatory mediators involved in COVID-19 hyperinflammatory state, targeting NF-κB pathway has been proposed to ameliorate severe inflammation in COVID-19 [108, 109] .

Monocyte-derived macrophages are involved in lung and multiorgan inflammation observed in severe COVID-19 patients [110] [111] [112] which necessitate the investigation of potential natural phenolic compounds that could reduce NF-κB activation and inhibit the production of proinflammatory cytokines and chemokines by macrophages.

The anti-inflammatory activity of some natural compounds is due to their ability to impair NF-κB activation. The in vitro suppression of NF-κB pathway by amentoflavone, herbacetin, rhoifolin, luteolin, myricetin, psoralidin, scutellarin and hesperetin has been described in RAW 264.7 murine macrophages. Amentoflavone decreased NO production by LPS-activated RAW 264.7 macrophages, and this activity was dose dependent [113, 114] . RAW 264.7 cells, that were pretreated with 60 µM of amentoflavone, showed reduced NF-κB activation and translocation of p65 to the nucleus. Moreover, inducible nitric oxide synthase (iNOS) expression and NO production were reduced in these cells [113] . Herbacetin exerts its anti-inflammatory effects by inhibiting Jun N-terminal kinase (JNK) and NF-κB signaling pathway in RAW 264.7. Herbacetin (50 µM) reduced the production of NO, IL-1β and TNF-α in cells that are stimulated with LPS [115] . Rhoifolin (100 µmol/L) suppressed IκBα and IKKβ phosphorylation in RAW 264.7 cells, that are stimulated with LPS, resulting in reduced production of TNF-α, IL-1β and IL-6 cytokines, and lower levels of iNOS and CCL2 mRNA [116] . Furthermore, luteolin (5 µM) impaired NFκB translocation in LPS-activated RAW 264.7 cells, induced heme oxygenase-1 (HO-1) expression, and reduced iNOS expression and NO production [117] . Similarly, myricetin (100 µM) impaired STAT-1 activation, IκBα degradation, and the p65 nuclear translocation, and induced heme HO-1 expression in LPS-stimulated RAW 264.7 cells [118] . Psoralidin (30 µM) inhibited iNOS expression in LPS-activated RAW 264.7 cells by suppressing IKK phosphorylation, IκB degradation and NF-κB nuclear translocation [119] . In addition, pretreatment with 100 µM scutellarin decreased the production of prostaglandin E 2 (PGE 2 ), NO, IL-6 and TNF-α by LPS-activated RAW 264.7 cells [120] . Hesperetin exerts anti-inflammatory effects in LPS-stimulated RAW 264.7 since treatment with 40 µM decreased TNF-α, IL-6, IL-1β production, and reduced iNOS and COX-2 expression by impairing NF-κB activation and stimulation of HO-1 and nuclear factor erythroid 2-related factor 2 (Nrf2) pathways [121] .

In human monocytes, 10 µM of apigenin decreased IL-1β, TNF-α and IL-8 production by cells stimulated with LPS. This anti-inflammatory activity of apigenin is due to inhibition of NF-κB activation by reducing the phosphorylation of p65 and inhibiting IKK [122] . Another study have shown that pre-treatment of LPS-stimulated THP-1-derived macrophages, with 25 µM of apigenin, blocked ERK1/2 phosphorylation, impaired NF-κB activation, and decreased the expression of chemokine (C-C motif) ligand 5 (CCL5), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion protein-1 (VCAM-1), IL-1β, and IL-6 [123] .

Also, THP-1 macrophages that were pre-treated with 40 µM catechin, before infection with Porphyromonas gingivalis, showed downregulation of NF-κB activation, and reduced IL-1β and TNF-α production with no effect on bacterial growth [124] .

EGCG can directly bind to CXCL9, 10 and 11 chemokines and limit their ability to recruit leukocytes [125] . In addition, pre-treatment with 10 µM EGCG, quercetin and luteolin reduced inflammation in endothelial cells by impairing IKKB activation and downregulating VCAM-1 expression [126] . Another study have demonstrated that EGCG and GCG in a concentration dependent manner (0.3 and 30 µM) blocked IκBα degradation, NF-κB activation and IL-12p40 production in LPS-stimulated murine peritoneal macrophages and J774.1 macrophages, and these effects were dose dependent [127] . Similarly, luteolin (10 and 100 µM) inhibited VCAM-1 expression on formyl-MLP (fMLP)-stimulated endothelial cells [128] . In the same study, luteolin suppressed the adhesion of monocytes to endothelial cells by reducing chemokine monocyte chemotactic protein-1 (MCP-1), ICAM-1 and VCAM-1 expression by endothelial cells stimulated with TNF-α. Such effects were explained by the ability of luteolin to inhibit NF-κB activation by impairing IκBα degradation, IκB kinase β (IKKβ) expression, and NF-κB nuclear translocation in endothelial cells [129] . Another study showed that isobavachalcone impaired NF-κB activation and ICAM-1 expression in a cerebrovascular endothelial cell line that was stimulated with LPS, polyriboinosinic polyribocytidylic acid (Poly [I:C]) or macrophage-activating lipopeptide 2-kDa (MALP-2). In line with the above findings, as well as at 0,1, 1 or 5 µM isobavachalcone inhibited the adhesion of monocytes to LPS-stimulated endothelial cells in vitro [130] .

Studies showed that resveratrol impaired NF-κB activation in different cells including myeloid cells, HeLa, and Jurkat cells that were stimulated with phorbol myristate acetate (PMA), LPS, H 2 O 2 , okadaic acid or ceramides [131] . Indeed, human and murine macrophages stimulated with TNF-α or LPS in the presence of 25 µM of resveratrol showed reduced production of proinflammatory cytokine and chemokine [132] . In human epithelial cells, high concentration of resveratrol (300 µM) inhibited rhinovirus replication and ICAM-1 expression, and decreased basal levels of IL-6 and RANTES in uninfected human epithelia [133] .

Impaired NF-κB and reduced production of AP-1-dependent proinflammatory cytokines were described in LPS-stimulated RAW 264.7 macrophages that were pre-treated with 20 µM of quercetin. The ability of quercetin to impair TLR4/MyD88/PI3K downstream signaling pathways resulted in reduced production of NO, PGE 2 , TNF-α, IL-6, IL-1β and GM-CSF [134] . Interestingly, synergistic anti-inflammatory activity of quercetin and catechin was detected in LPS-stimulated RAW 264.7 macrophages that were treated with 3 µM of quercetin and 75 µM of catechin [135] . Pre-treatment with quercetin inhibited nuclear translocation of NF-κB p65 in human peripheral blood mononuclear cells (PBMCs) that were stimulated with oxidized low-density lipoprotein (OxLDL). Moreover, quercetin (25 µM) decreased PGE 2 and IL-6 production, and downregulated TLR2 and TLR4 expression in these PBMCs [136] . The anti-inflammatory effects of hesperetin and resveratrol (100 µM) were reported in PBMCs that were stimulated with LPS. Pre-treatment with hesperetin or resveratrol, 2 h prior to stimulation, reduced the production of TNF-α, IFN-γ, CCL-2, CCL-5, IL-1β and GM-CSF, while only resveratrol inhibited IL-6 production [137] .

BV-2 cells, a mouse microglial cell line, were used to study neuroinflammation in vitro [138] . Isobavachalcone, at 5 µM, suppressed p65 translocation to the nucleus and NF-κB activation in LPS-stimulated BV-2 cells, resulting in decreased expression of TNF-α, IL-6, IL-1β, and iNOS [139] . Scutellarin showed similar effects in LPS-stimulated BV-2 cells. In this study, 139.7 µM of scutellarin reduced AKT, JNK, p38 and p65 phosphorylation and suppressed the production of NO, TNF-α, IL-1β, and IL-6 [140] .

Studies showed that helichrysetin possessed anti-inflammatory, anti-oxidant and antitumor activities in different cell lines [141, 142] . Helichrysetin (50 µM) impaired NF-κB activation in mouse pancreatic β-MIN-6 cells [141] , HeLa, and T98G cells [142] . Rheumatoid arthritis fibroblast-like synoviocytes treated for 48h with 10 or 20 µM of pectolinarin showed decreased activation of the phosphatidylinositol 3 kinase/protein kinase B pathway, reduced cell proliferation and decreased production of IL-6, IL-18, NO and PGE 2 [143] . However, in LPS-stimulated RAW 264.7 macrophages, pectolinarin at 1, 10, 25 or 50 µM did not affect COX-2 expression and PGE 2 synthesis [144] . Table 3 summarizes the antiinflammatory activities of phenolic compounds discussed in this study. LPS-stimulated proliferation of TNF-α, IL-1β, IL-6 and NO production [140] The compounds in the table are in the order in which the compounds are presented in the section Effects of Natural Phenolic Compounds on NF-κB Pathway and Inflammation. 

Viral nucleic acids are recognized by PRRs, such as TLR 3,7,8 in the endosomes [145] . Recognition of viral proteins and nucleic acid by PRRs triggers myeloid differentiation primary response 88 (MyD88) and TIR-domain-containing adapter-inducing interferon-β (TRIF) signaling pathways culminating in the activation of interferon-regulatory factor 3/7 (IRF) and NF-κB transcription factors resulting in expression of pro-IL1β and pro-IL-18 [107] . Moreover, activation of cytosolic NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome by pathogens, including viruses, results in activation of caspase-1, and consequently the processing of pro-IL-1β and pro-IL-18 into mature IL-1β and IL-18 [146, 147] . It is noteworthy to mention that the activation of inflammatory caspases can induce a type of cell death called pyroptosis, which may be involved in exacerbated production of inflammatory cytokines during acute phase of COVID-19 [68, 148] . Those events are important in the defense against infectious diseases but could promote inflammation, death and tissue injury.

LDH is a marker for pyroptosis and is induced in severe COVID-19 patients [79] . Moderate and severe COVID-19 patients showed enhanced NLRP3 activation in PBMCs and lungs, which positively correlated with the severity of disease [149] . Treatments targeting NLRP3 inflammasome have been suggested to mitigate COVID-19-associated inflammation and complications [150] . Natural inhibitors of NLRP3 activation have been described, for example, amentoflavone [151] , quercetin [152] , apigenin [123] , catechin [124] , resveratrol [153] , luteolin [154] , scutellarin [155] , epigallocatechin gallate [126] , and myricetin [156] ( Figure 2 ). Natural phenolic compounds target NF-κB and NLRP3 pathways. Some compounds inhibit the activation or translocation of NF-κB to the nucleus, as well as inhibit NLRP3 inflammasome assembly. These actions impair the expression of inflammatory cytokines and the secretion of mature IL-1β. The inhibitory activities of natural phenolic compounds on NLRP3 inflammasome and NF-κB signaling pathways ameliorate exacerbated immune activation and reduces proinflammatory cytokines production during infections (Dashed lines = Inhibition. Green, blue, pink and gray balls represent inflammatory cytokines = IL-1β, IL-6, TNF-α and IL-12, respectively).

A study has shown that quercetin, at 100 µM, inhibited caspase-recruitment domain (ASC) oligomerization and NLRP3 inflammasome activation resulting in decreased IL-1β production by in vitro-stimulated macrophages [152] . Moreover, in a Kawasaki disease experimental model, treatment of mice with 100 mg/kg of quercetin prevented vascular inflammation and IL-1β production [152] . It was also found that treatment of macrophages with 25 µM apigenin blocked caspase-1 activation by targeting ASC and impairing NLRP3 inflammasome assembly [123] . Endoplasmic reticulum (ER) stress induced by palmitate in EA.hy926 cells, a hybridoma line derived from human endothelium and A549/8 cells, led to NLRP3 activation, IL-1β production and endothelial cell dysfunction. However, treatment of EA.hy-926 cells with 10 µM of quercetin, luteolin or epigallocatechin gallate reduced reactive oxygen species (ROS) production and thioredoxin-interacting protein (TXNIP) and NLRP3 inflammasome activation, resulting in lower IL-1β expression [126] . Moreover, EGCG (25 µM) reduced nucleus pulposus cell inflammation and cell death, induced by H 2 O 2, by interfering with cGAS/Sting/NLRP3 pathway [157] .

Resveratrol, at 5 µM, inhibited assembly and activation of NLRP3 inflammasome in stimulated macrophages [153] . Also, resveratrol (30 µM) inhibited NLRP3 and IL-1β expression in BV-2 cells, and protected septic mice from encephalopathy by targeting NLPR3 at a concentration of 30 mg/kg [158] .

Amentoflavone (10 µM) inhibited NLRP3 inflammasome activation in LPS-stimulated BV-2 cells [151] . Luteolin at a low concentration (2 µM) impaired NLRP3, ASC and caspase-1 expression by LPS-stimulated RAW 264.7 macrophages, and polarized macrophages into M2 macrophages by enhancing the expression of Arg-1 and IL-10, and decreasing M1 markers expression, including TNF-α, IL-6 and iNOS [154] . In addition, myricetin (75 µM) inhibited NLRP3 activation by blocking ASC oligomerization in macrophages [156] .

Scutellarin has also been shown to inhibit NLRP3 inflammasome activation in different experimental models [155, [159] [160] [161] [162] [163] . Treatment of LPS-primed bone-marrow derived macrophages (BMDMs) with 400 µM of scutellarin followed by ATP resulted in enhanced PKA signaling, reduction of ASC oligomerization, impaired caspase-1 activation, and lower IL-1β production compared to BMDMs that were not treated with scutellarin [155] . Figure 2 illustrates the anti-inflammatory activities of natural phenolic compounds by targeting NF-κB and/or NLRP3 inflammasome.

Sepsis manifestations including cytokine storm, endothelial cell dysfunction, intravascular coagulation, pulmonary, cardiovascular, and renal complications have all been reported in COVID-19 patients [164, 165] . Dysregulated immune response and cytokine storm [166] , with elevated levels of IL-6, IL-10, and TNF-α, and lymphopenia, correlated with worse outcomes in COVID-19 patients [167] . Therefore, anti-inflammatory and anti-coagulant drugs could be considered to reduce hyperinflammation and incidence of thrombosis, multiple organ failure and death [168] .

Experimental models to study sepsis include, for example, cecum ligation and puncture (CLP) and LPS lethal dose, since LPS binds to TLR4 which activates NF-κB and IRF3 pathways inducing the production of proinflammatory cytokines and cellular activation [169, 170] .

TLR4 is activated by Ebola virus (EBO), vesicular stomatitis virus (VSV), DENV, and SARS-CoV-2 [171, 172] . It has been shown that SARS-CoV-2 s spike protein activates TLR4 and triggers IL-1β and IL-6 production by THP-1 cells [172] . In addition, lung tissue injury, caused by SARS-CoV-2 infection, could induce danger associated molecular patterns (DAMPs) which activate TLR-4 and potentiate inflammation [171] . Therefore, the anti-inflammatory activities of natural phenolic compounds could be useful in severe inflammation and lung injury associated with COVID-19.

EGCG is among the natural phenolic compounds that inhibit TLR signaling. EGCG inhibited TLR4 signaling and ameliorated acute lung injury in mice infected with H9N2 influenza virus [173] . Resveratrol was also found to impairs TLR4 and TLR3 pathways independent of MyD88 signaling [174] . In addition, resveratrol suppressed RSV replication, IL-6 secretion and TRIF-TBK1 pathway in 9HTEo cells; human epithelium tracheal cells, that are infected and treated with 100 µM of resveratrol [175] . In vivo, resveratrol (30 mg/kg) reduced RSV titer in the lungs of infected mice, and impaired TLR3-TRIF signaling pathway, alleviating airway hyperresponsiveness and inflammation [176] .

Amentoflavone and apigenin were shown to reduce inflammation in sepsis models. In CLP-induced sepsis, amentoflavone treatment (50 mg/kg) protected rats from acute lung injury by decreasing TNF-α and IL-1β levels, impairing NF-κB activity and reducing oxidative stress in the lung tissue [177] . Mice treated with 50 mg/kg of apigenin, 3h before receiving a lethal dose of LPS, showed enhanced survival with decreased lung cell death, and reduced TNF-α production and neutrophil infiltration into the lung tissue. In addition, cardiac function and heart mitochondrial complex I activity were restored in these mice [178] .

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are also described in COVID-19 patients, and correlated with worse outcome and higher mortality [179] . Hesperetin demonstrated the ability to suppress inflammatory cytokines production, inflammatory cell infiltration into the lung tissue, and reduced myeloperoxidase and LDH activities in different models of ALI [180] [181] [182] .

Besides the importance of neutrophils in early responses to infections, they can damage tissues and are also involved in sepsis-induced tissue injury [183] . It has been shown that neutrophils accumulate in lungs of severe COVID-19 patients [184] . Neutrophilextracellular traps (NETs) were detected in high levels in the plasma and lung tissues of COVID-19 patients [185] , indicating that neutrophils activation is detrimental in COVID-19 patients. A study has shown that luteolin (30 µM) inhibited oxidative stress, and reduced NETs formation in human neutrophils that were activated with PMA [186] . Amentoflavone impaired oxidative burst in human neutrophils stimulated with PMA and protected human erythrocytes from oxidative hemolysis. These effects were explained by the ability of amentoflavone to inhibit NADPH oxidase and ROS production in human neutrophils and to prevent membrane damage and lipid peroxidation in human erythrocytes [187] . However, more studies are needed to further understand the mechanism by which amentoflavone inhibit neutrophil oxidative burst and erythrocyte lysis.

Neurologic symptoms have been described in COVID-19 patients, including anosmia, ageusia, encephalopathy, seizures, encephalitis, stroke, and cognitive disturbance [188, 189] . SARS-CoV-2 have been shown to infect neurons and damage the central nervous system (CNS) [190, 191] . The detection of low or no viral copies in the brain tissue has been described in a number of COVID-19 cases with neurologic complications [192] , and it remains unclear whether the CNS complications are caused by direct infection or inflammation. Seizures are among the neurologic complications that have been reported during and after recovery from SARS-CoV-2 infection [193] [194] [195] . Brain inflammation, genetic factors, developmental dysfunction, environmental risk and neurological insults are involved in epileptogenesis and seizures susceptibility [196] . Amentoflavone has been described as neuroprotective in experimental models of epilepsy. Amentoflavone suppressed NF-κB activation, decreased production of NO, PGE 2 , IL-1β, and IL-6, prevented hippocampus neurons apoptosis, and decreased epileptic seizures in pilocarpine-treated mice [197] . Moreover, amentoflavone blocked apoptosis, impaired NLRP3 inflammasome activation, and decreased production of IL-18, IL-1β, and TNF-α in brains of pentylenetetrazole-induced kindling mice [151] .

The anti-inflammatory, anti-oxidant and anti-apoptotic effects of hesperetin have been related to its ability to protect neuronal [198, 199] , cardiac [200] and renal tissues [201] in different injury models. Hesperetin ameliorated neuroinflammation, memory, and impaired neuronal apoptosis in vivo [198] . Hesperetin interfered with the TLR4-NF-κB signaling pathway. Accordingly, mice treated with LPS and hesperetin (50 mg/kg) showed decreased brain levels of p-NF-κB, IL-1β and TNF-α compared to mice that received only LPS. The anti-inflammatory and cytoprotective effects of hesperetin were also confirmed in vitro using BV-2, and HT-22 mouse hippocampal neuronal cell line [198] .

Acute myocarditis is one of the extrapulmonary complications in COVID-19 patients [202] , and is associated with inflammatory cell infiltration into the heart tissue [203] . It has been shown that apigenin prevented myocarditis in an experimental model of autoimmune myocarditis. Treatment with 200 mg/Kg (gavage) of apigenin reduced inflammatory cell infiltration into the heart, decreased TNF-α, IL-2 and IFN-γ, and ameliorated cardiac dysfunction compared to untreated mice [204] . Anti-apoptotic effects of 25 µM of hesperetin was also demonstrated in in vitro LPS-treated H9C2 cardiomyocytes [205] , and in a myocardial infarction (MI) model in vivo. Indeed MI mice, treated with 30 mg/kg/day of hesperetin for 8 weeks, showed impaired NF-κB activation, reduced cardiac fibrosis and inflammation compared to untreated MI-mice [200] .

Kawasaki-like disease (KD) was also described in COVID-19 pediatric patients [206] . Proinflammatory cytokines are related to hyperinflammation, vasculitis and coronary artery damage in KD patients. Increased TNF-α and IL-1β levels in KD patients result in endothelial cell activation and expression of adhesion molecules which leads to leukocyte adherence and endothelial injury, promoting vasculitis and coronary artery aneurysms [207] . Human coronary arterial endothelial cells, activated with 10 ng/mL of TNF-α, showed enhanced VCAM-1 and ICAM-1 expression, oxidative stress and proinflammatory cytokines production. However, in the presence of 10 µM of resveratrol, expression of ICAM-1, iNOS, and IL-1β were reduced which indicate that resveratrol has anti-inflammatory actions on coronary arterial cells and could be promising in treatment of KD patients [208] . Moreover, quercetin treatment (50 mg/kg) prevented cardiac injury, inflammation and oxidative stress in the heart of streptozocin (STZ) and nicotinamide-induced diabetic rats [209] . Luteolin (10 µM) protected H9C2 cardiomyocytes from inflammation and oxidative stress induced by high glucose concentration. Additionally, reduced inflammation was observed in the heart of STZ-diabetic mice that were treated with 20 mg/kg of luteolin for 15 weeks [210] . Figure 3 illustrates the main mechanisms of the immunomodulatory actions of phenolic compounds discussed in this study. Most of the compounds discussed in this review are found in foods and beverages of natural origin, such as resveratrol, which is commonly present in wine. However, it is not possible to conclude that a diet based on these foods will result in prevention or improvement of the clinical conditions of affected people by COVID-19. Discussion of this possibility requires carrying out comprehensive studies in populations that have an appropriate diet. For example, the high consumption of wine in France may contribute to the low frequency of coronary heart disease, possibly due to the presence of resveratrol in this drink. This evidence represents the French paradox [211] . However, countries with high consumption of wine, such as France and Italy, had a high number of deaths caused by COVID-19 [212, 213] . Therefore, studies using standardized methods with these phytoconstituents are needed to advance the knowledge of their therapeutic potential against COVID-19.

Among natural phenolic compounds discussed, we highlighted the antiviral effects of quercetin, luteolin, resveratrol, and amentoflavone against coronaviruses as well as their ability to modulate immune response and inflammatory status in a variety of in vitro and in vivo models. Despite the structural complexity of some bioactive compounds, there are perspectives for the development of synthetic analogues with an anticoronavirus and immunomodulator profile, but structurally simpler and easier to obtain using the phytoconstituents in this review as prototypes. In addition, it is possible to manufacture plant products containing a significant amount of these phenolic compounds and use them as potentially therapeutic agents against COVID-19. So, further experimental studies focusing on anti-SARS-CoV-2 and immunomodulatory activities of these compounds are needed. 

The authors declare no conflict of interest.

Human coronavirus-229E (+ss)

Positive single-stranded 3CL pro 3-Chymotrypsin-like protease ACE2

Angiotensin 50 Concentration that results in 50% inhibition CC 50 Concentration that reduces cell viability by 50%

Coronavirus genomics and bioinformatics analysis. Viruses

Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus

Human coronaviruses: A review of virus-host interactions

A novel coronavirus from patients with pneumonia in China

Antiviral potentials of medicinal plants

Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: An overview

Phenolic compounds as natural and multifunctional anti-obesity agents: A review

Identification of major phenolic compounds from nephelium lappaceum l. And their antioxidant activities

Comprehensive characterisation of polyphenols in leaves and stems of three anti-dengue virus type-2 active Brazilian Faramea species (Rubiaceae) by HPLC-DAD-ESI-MS/MS

Preparation of molecularly imprinted polymers coupled with high-performance liquid chromatography for the selective extraction of salidroside from Rhodiola crenulata

Isolation of punicalagin from Punica granatum rind extract using mass-directed semi-preparative ESI-AP single quadrupole LC-MS

Mechanisms of action of cytotoxic phenolic compounds from glycyrrhiza iconica roots

Flavonoids: An overview

Antiviral chemotherapy. V. Further report on flavonoids

Study on the effect of flavonoids and related substances. I. The effect of quercetin on different viruses

Quercetin as an antiviral agent inhibits influenza a virus (IAV) entry. Viruses

Activity of some flavonoids against viruses

Antiviral effect of flavonoids on human viruses

Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with transacting factors

Effects of propolis flavonoids on virus infectivity and replication. Microbiol

Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus

Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells

Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection

SARS-beginning to understand a new virus

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition

Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris

Inhibition of SARS-CoV 3CL protease by flavonoids

Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia

Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors

Development of chemical inhibitors of the SARS coronavirus: Viral helicase as a potential target

Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives

Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection

Epigallocatechin gallate inhibits the uridylate-specific endoribonuclease Nsp15 and efficiently neutralizes the SARS-CoV-2 Strain

GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro

Myricetin inhibits SARS-CoV-2 viral replication by targeting mpro and ameliorates pulmonary inflammation

Quercetin and its metabolites inhibit recombinant human angiotensinconverting enzyme 2 (ACE2) Activity

Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication

Effective inhibition of MERS-CoV infection by resveratrol

Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells

Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking

Molecular docking studies on the anti-viral effects of compounds from kabasura kudineer on SARS-CoV-2 3CLpro

Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in silico study for drug development

In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis

Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review

Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study

Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)

Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2

In silicoanalysis of the interactions of certain flavonoids with the receptor-binding domain of 2019 novel coronavirus and cellular proteases and their pharmacokinetic properties

Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: An integrated computational approach

Silico Screening of natural products isolated from mexican herbal medicines against COVID-19

Flavonoids as potential therapeutics against novel coronavirus disease-2019 (nCOVID-19)

In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2

Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: An in silico docking and molecular dynamics simulation approach

Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis

Potential of Flavonoid-Inspired Phytomedicines against COVID-19

Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors-anin silicodocking and molecular dynamics simulation study

Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor

Natural agents modulating ACE-2: A review of compounds with potential against SARS-CoV-2 infections

Innate immunity to virus infection

Regulating the adaptive immune response to respiratory virus infection

Recognition of microorganisms and activation of the immune response

Clinical features of patients infected with 2019 novel coronavirus in

Cytokine elevation in severe and critical COVID-19: A rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Human type I interferon antiviral effects in respiratory and reemerging viral infections

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Activation and evasion of type I interferon responses by SARS-CoV-2

Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

Extrapulmonary manifestations of COVID-19

Alisjahbana, B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: A meta-analysis

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

COVID-19 as an acute inflammatory disease

Global pandemics interconnected-obesity, impaired metabolic health and COVID-19

COVID-19 patients with hypertension have more severe disease: A multicenter retrospective observational study

Comorbidities in SARS-CoV-2 patients: A systematic review and meta-analysis

Co-infections in people with COVID-19: A systematic review and meta-analysis

Natural compounds with dual antimicrobial and anti-inflammatory effects

Flavonoids Activation of the transcription factor Nrf2 as a hypothesis approach for the prevention and modulation of SARS-CoV-2 infection severity

Effects of flavonoids and its derivatives on immune cell responses. Recent Patents Inflamm

Antiviral and immunomodulatory effects of phytochemicals from honey against COVID-19: Potential mechanisms of action and future directions

Therapeutic potential of resveratrol against emerging respiratory viral infections

Flavones induce immunomodulatory and anti-inflammatory effects by activating cellular anti-oxidant activity: A structure-activity relationship study

Epigallocatechin-3-gallate enhances poly I: C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes

−)-Epigallocatechin-3-gallate enhances hepatitis c virus doublestranded RNA intermediates-triggered innate immune responses in hepatocytes

Epigallocatechin gallate (EGCG), influences a murine WEHI-3 leukemia model in vivo through enhancing phagocytosis of macrophages and populations of T-and B-cells

Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia

Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model

Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies

Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression

Anti)mutagenic and immunomodulatory properties of quercetin glycosides

Role of dietary antioxidants in human metapneumovirus infection

Eupatorium fortunei and its components increase antiviral immune responses against RNA viruses

Epimedium koreanum Nakai displays broad spectrum of antiviral activity in vitro and in vivo by inducing cellular antiviral state

Preclinical evaluation of the antimicrobial-immunomodulatory dual action of xenohormetic molecules against haemophilus influenzae respiratory infection

Protective effects of flavonoids against microbes and toxins: The cases of hesperidin and hesperetin

Potential antivirals and antiviral strategies against SARS coronavirus infections

Immunomodulatory potential of hesperetin and chrysin through the cellular and humoral response

Hesperetin as an adjuvant augments protective anti-tumour immunity responses in B16F10 melanoma by stimulating cytotoxic CD8 + T cells

NF-κB signaling in inflammation

The role and therapeutic potential of nf-kappa-b pathway in severe COVID-19 patients

NF-κB pathway as a potential target for treatment of critical stage COVID-19 patients

Role of monocytes/macrophages in covid-19 pathogenesis: Implications for therapy

Imbalanced host response to SARS-CoV-2 drives development of COVID-19

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Amentoflavone inhibits the induction of nitric oxide synthase by inhibiting NF-κB activation in macrophages

Anti-inflammatory phenolics isolated from Juniperus rigida leaves and twigs in lipopolysaccharide-stimulated RAW264.7 macrophage cells

Herbacetin inhibits inducible nitric oxide synthase via JNK and nuclear factor-κB in LPS-stimulated RAW264.7 cells

Rhoifolin Alleviates inflammation of acute inflammation animal models and LPS-Induced RAW264.7 cells via IKKβ/NF-κB signaling pathway

Anti-inflammatory activity of butein and luteolin through suppression of NFκB activation and induction of heme oxygenase-1

Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-κB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages

Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IκB signaling pathways

Effect of Siam weed extract and its bioactive component scutellarein tetramethyl ether on anti-inflammatory activity through NF-κB pathway

Hesperetin suppresses inflammatory responses in lipopolysaccharideinduced RAW 264.7 cells via the inhibition of NF-κB and activation of Nrf2/HO-1 pathways

Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation

Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages

Catechin ameliorates Porphyromonas gingivalis induced inflammation via the regulation of TLR2/4 and inflammasome signaling

Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment

Quercetin, luteolin and epigallocatechin gallate alleviate TXNIP and NLRP3-mediated inflammation and apoptosis with regulation of AMPK in endothelial cells

Effect of various catechins on the IL-12p40 production by murine peritoneal macrophages and a macrophage cell line, J774.1

Luteolin suppresses inflammation through inhibiting cAMPphosphodiesterases activity and expression of adhesion molecules in microvascular endothelial cells

Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IKBα/NF-κB signaling pathway

Isobavachalcone attenuates lipopolysaccharide-induced ICAM-1 expression in brain endothelial cells through blockade of toll-like receptor 4 signaling pathways

Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation

Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells

Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia

Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κBinduced inflammatory mediators production in RAW 264.7 cells

Synergistic anti-inflammatory effects of quercetin and catechin via inhibiting activation of TLR4-MyD88-mediated NF-κB and MAPK signaling pathways

Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway

Leukocyte Production of Inflammatory mediators is inhibited by the antioxidants phloretin, silymarin, hesperetin, and resveratrol

The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation

Isobavachalcone attenuates MPTP-induced parkinson's disease in mice by inhibition of microglial activation through NF-κB pathway

Scutellarin suppresses neuroinflammation via the inhibition of the AKT/NF-κB and p38/JNK pathway in LPS-induced BV-2 microglial cells

Amides and flavonoids from the fruit and leaf extracts of melodorum siamensis

Helichrysetin and TNF-α synergistically promote apoptosis by inhibiting overactivation of the NF-κB and EGFR signaling pathways in HeLa and T98G cells

Pectolinarin inhibits proliferation, induces apoptosis, and suppresses inflammation in rheumatoid arthritis fibroblast-like synoviocytes by inactivating the phosphatidylinositol 3 kinase/protein kinase B pathway

Anti-inflammatory activity of pectolinarigenin and pectolinarin isolated from cirsium chanroenicum

Coronavirus infections and immune responses

Converging roles of caspases in inflammasome activation, cell death and innate immunity

NLRP3 inflammasome: The stormy link between obesity and COVID-19

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

Inflammasomes and pyroptosis as therapeutic targets for COVID-19

Amentoflavone affects epileptogenesis and exerts neuroprotective effects by inhibiting NLRP3 inflammasome

Quercetin inhibits inflammasome activation by interfering with ASC oligomerization and prevents interleukin-1 mediated mouse vasculitis

Resveratrol inhibits the acetylated α-tubulin-mediated assembly of the NLRP3-inflammasome

Luteolin alleviates NLRP3 inflammasome activation and directs macrophage polarization in lipopolysaccharide-stimulated RAW264.7 cells

Scutellarin suppresses NLRP3 inflammasome activation in macrophages and protects mice against bacterial sepsis

Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination

Epigallocatechin-3-Gallate Protects H 2 O 2 -Induced Nucleus Pulposus Cell Apoptosis and Inflammation by Inhibiting cGAS/Sting/NLRP3 Activation. Drug Des

Resveratrol protects against sepsisassociated encephalopathy and inhibits the NLRP3/IL-1βAxis in microglia

Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation

Scutellarin ameliorates renal injury via increasing CCN1 expression and suppressing NLRP3 inflammasome activation in hyperuricemic mice

Scutellarin protects against lipopolysaccharide-induced behavioral deficits by inhibiting neuroinflammation and microglia activation in rats

Protective effects of Erigeron breviscapus Hand.-Mazz. (EBHM) extract in retinal neurodegeneration models

Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation

COVID-19-associated acute kidney injury: Consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup

COVID-19 sepsis and microcirculation dysfunction

COVID-19: Consider cytokine storm syndromes and immunosuppression

Clinical and immunological features of severe and moderate coronavirus disease 2019

Sepsis and coronavirus disease 2019: Common features and anti-inflammatory therapeutic approaches

Experimental models of sepsis and their clinical relevance

Recognition of lipopolysaccharide pattern by TLR4 complexes

Toll-like receptor 4 in acute viral infection: Too much of a good thing

SARS-CoV-2 spike protein interacts with and activates TLR41

Epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor and effectively alleviates acute lung injury induced by H9N2 swine influenza virus

Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex

Resveratrol inhibits respiratory syncytial virusinduced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells

Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice

Amentoflavone prevents sepsis-associated acute lung injury through Nrf2-GCLc-mediated upregulation of glutathione

Dietary apigenin exerts immune-regulatory activity in vivo by reducing NF-κB activity, halting leukocyte infiltration and restoring normal metabolic function

Acute lung injury in patients with COVID-19 infection

Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2

Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4-MyD88-NF-κB signaling pathway

Hesperetin attenuates ventilator-induced acute lung injury through inhibition of NF-κB-mediated inflammation

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Excessive neutrophils and neutrophil extracellular traps in COVID-19

SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology

Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activity

Redox-active biflavonoids from Garcinia brasiliensis as inhibitors of neutrophil oxidative burst and human erythrocyte membrane damage

Lifting the mask on neurological manifestations of COVID-19

Neurological issues during COVID-19: An overview

SARS-CoV-2 infects human neural progenitor cells and brain organoids

SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability

Neuropathology of patients with COVID-19 in Germany: A post-mortem case series

COVID-19 Presenting with Seizures

Non-lesional status epilepticus in a patient with coronavirus disease 2019

Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus

The role of inflammation in the development of epilepsy

Amentoflavone protects hippocampal neurons: Anti-inflammatory, antioxidative, and antiapoptotic effects

Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling

Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways

Hesperetin protects against inflammatory response and cardiac fibrosis in postmyocardial infarction mice by inhibiting nuclear factor κB signaling pathway

Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis

COVID-19 and acute myocarditis: Current literature review and diagnostic challenges

Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions

Apigenin attenuates experimental autoimmune myocarditis by modulating Th1/Th2 cytokine balance in mice

Hesperetin attenuates mitochondriadependent apoptosis in lipopolysaccharide-induced H 9 C 2 cardiomyocytes

Kawasaki-like disease in children with COVID-19

Kawasaki disease: Pathophysiology and insights from mouse models

Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: Implication for the treatment of Kawasaki disease

Quercetin ameliorates oxidative stress, inflammation and apoptosis in the heart of streptozotocin-nicotinamide-induced adult male diabetic rats

Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses

French and Mediterranean-style diets: Contradictions, misconceptions and scientific facts-A review

The SARS-CoV-2 coronavirus and the COVID-19 outbreak

Fast tracking intensive care units and operation rooms during the COVID-19 pandemic in resource limited settings